Alignment Healthcare (ALHC) Expected to Announce Quarterly Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC) is expected to be issuing its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.18) per share and revenue of $676.02 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Alignment Healthcare Stock Up 3.4 %

ALHC stock opened at $13.63 on Tuesday. Alignment Healthcare has a 12 month low of $4.46 and a 12 month high of $15.82. The firm has a market cap of $2.61 billion, a PE ratio of -17.70 and a beta of 1.50. The firm has a 50 day simple moving average of $13.24 and a 200 day simple moving average of $11.84. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, CEO John E. Kao sold 90,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $11.65, for a total value of $1,048,500.00. Following the transaction, the chief executive officer now owns 2,363,100 shares in the company, valued at approximately $27,530,115. This represents a 3.67 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $13.61, for a total transaction of $408,300.00. Following the completion of the transaction, the president now owns 1,606,097 shares in the company, valued at approximately $21,858,980.17. This represents a 1.83 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 476,002 shares of company stock worth $6,220,726. 6.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

ALHC has been the subject of several recent research reports. Stifel Nicolaus increased their target price on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Tuesday, January 14th. Stephens restated an “overweight” rating and issued a $17.00 price target on shares of Alignment Healthcare in a research report on Monday. Barclays upped their price target on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. Finally, UBS Group upped their price target on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research report on Wednesday, October 30th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.